Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Anticoagulation Targets in ECLS (RATE)

NCT04536272 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04536272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04536272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Anticoagulation Targets in ECLS (RATE)
Lead sponsor
University Medical Center Groningen
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2020
Completion date
March 7, 2025
Enrollment
330 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, extracorporeal membrane oxygenation, heart failure, respiratory failure, thrombosis